The latest updates from our US Policy Horizon Series

Filter your results by category

Showing All

Row of American flags gathered at their poles, with one in sharp focus and a soft twilight sky in the background.

US Policy

Three Models of MFN Announced

Date Published: June 18, 2026

American flag flying in front of the US Capitol building dome, symbolising US pharmaceutical policy reform.

US Policy

Supreme Court rejects Trump’s tariffs: What does this mean for pharma?

Date Published: June 18, 2026

The US Capitol building dome with an American flag, framed by green trees against a blue sky.

US Policy

Trump Administration announces 100% tariffs on pharmaceuticals

Date Published: June 18, 2026

The Evidence Base: Peek Behind the Poster" banner featuring Amanda Cole, Director at OHE, and Matthias Hofer, Senior Principal Economist at OHE, on the topic "How US drug pricing reforms are reshaping biopharma investment and innovation.

US Policy

How US drug pricing reforms are reshaping biopharma investment and innovation

Date Published: May 27, 2026

Wide view of the US Capitol building with its dome, colonnades, and an American flag, set against a blue sky with clouds.

OHE

Is the revised Congressional Budget Office model of new drug development fit for purpose?

Date Published: May 6, 2026

A Dose of Economics podcast graphic titled 'Most Favored Nation pricing: what it means for policy, patients and pharma,' featuring Neil Grubert, Independent Global Market Access Consultant, and Amanda Cole, Director at the Office of Health Economics.

OHE

Most Favored Nation pricing: what it means for policy, patients and pharma

Date Published: May 5, 2026

Close-up of the US and EU flags overlapping, showing white stars on the American flag and gold stars on the European Union flag, symbolising transatlantic pharmaceutical policy.

US Policy

Europe’s pharmaceutical policy choices – And what the United States stands to learn

Date Published: March 18, 2026